BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28694653)

  • 1. Attenuated adenomatous polyposis of the large bowel: Present and future.
    Roncucci L; Pedroni M; Mariani F
    World J Gastroenterol; 2017 Jun; 23(23):4135-4139. PubMed ID: 28694653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated polyposis of the large bowel: a morphologic and molecular approach.
    de Leon MP; Pedroni M; Roncucci L; Domati F; Rossi G; Magnani G; Pezzi A; Fante R; Bonetti LR
    Fam Cancer; 2017 Apr; 16(2):211-220. PubMed ID: 27783336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
    Claes K; Dahan K; Tejpar S; De Paepe A; Bonduelle M; Abramowicz M; Verellen C; Franchimont D; Van Cutsem E; Kartheuser A
    Acta Gastroenterol Belg; 2011 Sep; 74(3):421-6. PubMed ID: 22103048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial adenomatous polyposis.
    Half E; Bercovich D; Rozen P
    Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China.
    Li N; Kang Q; Yang L; Zhao XJ; Xue LJ; Wang X; Li AQ; Li CG; Sheng JQ
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1497-1503. PubMed ID: 31062380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation and Follow-up of Familial Adenomatous Polyposis: Differences Between APC and MUTYH Mutations.
    Bademci R; Bollo J; Ramón Y Cajal T; Martínez MC; Hernández MP; Targarona EM
    Cir Esp (Engl Ed); 2020 Oct; 98(8):465-471. PubMed ID: 32505560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.
    Pezzi A; Roncucci L; Benatti P; Sassatelli R; Varesco L; Di Gregorio C; Venesio T; Pedroni M; Maffei S; Reggiani Bonetti L; Borsi E; Ferrari M; Martella P; Rossi G; Ponz De Leon M
    Scand J Gastroenterol; 2009; 44(9):1092-100. PubMed ID: 19593690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
    Sokic-Milutinovic A
    Dig Dis; 2019; 37(5):400-405. PubMed ID: 30836352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUTYH-associated colon disease: adenomatous polyposis is only one of the possible phenotypes. A family report and literature review.
    Zorcolo L; Fantola G; Balestrino L; Restivo A; Vivanet C; Spina F; Cabras F; Ambu R; Casula G
    Tumori; 2011; 97(5):676-80. PubMed ID: 22158503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.
    Khan N; Lipsa A; Arunachal G; Ramadwar M; Sarin R
    Sci Rep; 2017 May; 7(1):2214. PubMed ID: 28533537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis.
    Burt RW; Leppert MF; Slattery ML; Samowitz WS; Spirio LN; Kerber RA; Kuwada SK; Neklason DW; Disario JA; Lyon E; Hughes JP; Chey WY; White RL
    Gastroenterology; 2004 Aug; 127(2):444-51. PubMed ID: 15300576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
    Cheng TH; Gorman M; Martin L; Barclay E; Casey G; ; ; Saunders B; Thomas H; Clark S; Tomlinson I
    Eur J Hum Genet; 2015 Feb; 23(2):260-3. PubMed ID: 24801760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
    Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
    Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c.1227_1228dupGG (p.Glu410Glyfs), a frequent variant in Tunisian patients with MUTYH associated polyposis.
    Kdissa A; Brusgaard K; Ksiaa M; Golli L; Hallara O; Ousager LB; Manoubi W; Seghaier RB; Adala L; Halleb Y; Saad A; Hmila F; Gribaa M
    Cancer Genet; 2020 Jan; 240():45-53. PubMed ID: 31739127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis.
    Zhang Z; Liang S; Huang H; Wang D; Zhang X; Wu J; Chen H; Wang Y; Rong T; Zhou Y; Banerjee S
    Oncotarget; 2016 Aug; 7(31):50392-50400. PubMed ID: 27391059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.